A Phase 1 Study Of Moxetumomab Pasudotox, An Anti-Cd22 Recombinant Immunotoxin, In Relapsed/Refractory Hairy Cell Leukemia (Hcl): Updated Results.Robert J. Kreitman,Martin S. Tallman,Steven Coutre,Tadeusz Robak,Wyndham H. Wilson,Maryalice Stetler-Stevenson,Pierre Noel,David J. FitzGerald,Manuela Buzoianu,Robert J. Lechleider,Ira PastanBLOOD(2010)引用 8|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要